These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8055127)

  • 1. Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials.
    Rossouw JE; Harlan WR
    Ann Epidemiol; 1994 May; 4(3):255-6. PubMed ID: 8055127
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of osteoporosis with estrogen].
    Mizunuma H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():397-403. PubMed ID: 15035159
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal estrogen and the risk of breast cancer.
    Barrett-Connor E
    Ann Epidemiol; 1994 May; 4(3):177-80. PubMed ID: 8055117
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Wood C; Cline M
    J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867
    [No Abstract]   [Full Text] [Related]  

  • 6. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 7. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 8. Are lower doses of estrogen effective against osteoporosis?
    Healthc Demand Dis Manag; 1999 Aug; 5(8):125-7. PubMed ID: 10557953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination hormone therapy tied to slight increase in breast cancer deaths.
    Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy in menopause].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopausal hormone replacement therapy and risk of breast cancer. Implications for the treatment of osteoporosis in postmenopausal women.
    Lopes P
    Rev Rhum Engl Ed; 1996 May; 63(5):309-11. PubMed ID: 8789875
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer risk.
    Melnikow J
    J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
    [No Abstract]   [Full Text] [Related]  

  • 16. Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots.
    Joshi PA; Goodwin PJ; Khokha R
    JAMA Oncol; 2015 Jun; 1(3):283-5. PubMed ID: 26181171
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer and estrogen replacement.
    N Engl J Med; 1990 Jan; 322(3):201-4. PubMed ID: 2152975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Bone loss after stopping estrogen or alendronate therapy.
    Ann Intern Med; 2002 Dec; 137(11):I31. PubMed ID: 12459003
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH workshop tries to create consensus on HRT use.
    Randal J
    J Natl Cancer Inst; 2003 Jan; 95(1):9-11. PubMed ID: 12509392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.